Tlajomulco de Zúñiga

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Ulcerative colitis2 trials

Phase

• Phase 22 trials

Status

• Enrolling by invitation1 trial
• Recruiting1 trial

Lead sponsor

• Spyre Therapeutics, Inc.2 trials

Running trials

• Enrolling by invitation

  Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD

  NCT07652294· Phase 2· Spyre Therapeutics, Inc.· Source

• Recruiting

  A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

  NCT07012395· Phase 2· Spyre Therapeutics, Inc.· Source

  Contact: SKYLINE-UC Trial Center

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Ulcerative colitis2 recruiting